Oct. 31, 2024

The American College of Radiology® (ACR®) issued a statement expressing strong support for the Medicare Patient Access and Practice Stabilization Act of 2024 introduced Oct. 29, in the U.S. House of Representatives. The bill was introduced by Rep. Greg Murphy, MD, (R-NC), joined by Reps. Jimmy Panetta (D-CA), Mariannette Miller-Meeks, MD, (R-IA), Ami Bera, MD, (D-CA), Bucshon, MD, (R-IN), Raul Ruiz, MD, (D-CA), John Joyce, MD, (R-PA), and Kim Schrier, MD, (D-WA). The legislation, strongly supported by the House of Medicine, would eliminate the 2025 Medicare Physician Fee Schedule (MPFS) conversion factor (CF) reduction scheduled to hit Jan. 1, and add an additional 1.8% to the CF to partially address inflationary costs.

ACR urges all College members to contact their representative and ask them to cosponsor and work to advance the Medicare Patient Access and Practice Stabilization Act of 2024. Passage of this bill is urgent; Congress must act soon to ensure stability for both physicians and Medicare beneficiaries in 2025.

For more information or if you have questions, contact Rebecca Spangler, Senior Government Relations Director.

Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more